APPLICATION
ANDA064124
TYPE
ANDA
ORIGINAL APPROVAL
1997-05-30
LATEST ACTION
2021-10-08
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
CEFUROXIME SODIUMDiscontinued
CEFUROXIME SODIUM EQ 7.5GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2021-10-08Labeling · Supplement 18 · standardAP
2008-07-31Labeling · Supplement 8AP
2007-11-16Labeling · Supplement 7AP
2007-06-20Labeling · Supplement 6AP
2007-01-31Labeling · Supplement 5AP
2004-09-30Labeling · Supplement 3AP
1999-09-23Manufacturing (CMC) · Supplement 1AP
1997-05-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.